Literature DB >> 34966957

Big Data/AI in Neurocritical Care: Maybe/Summary.

Jose I Suarez1.   

Abstract

Big data (BD) and artificial intelligence (AI) have increasingly been used in neurocritical care. "BD" can be operationally defined as extremely large datasets that are so large and complex that they cannot be analyzed by using traditional statistical modeling. "AI" means the ability of machines to perform tasks similar to those performed by human intelligence. We present a brief overview of the most commonly applied AI techniques to perform BD analytics and discuss some of the recent promising examples in the field of neurocritical care. The latter include the following: cognitive motor dissociation in disorders of consciousness, hypoxic-ischemic injury following cardiac arrest, delayed cerebral ischemia and vasospasm after subarachnoid hemorrhage, and monitoring of intracranial pressure. It is imperative that we develop multicenter collaborations to tackle BD. These collaborations will allow us to share data, combine predictive algorithms, and analyze multiple and cumulative sources of data retrospectively and prospectively. Once AI algorithms are validated at multiple centers, they should be tested in randomized controlled trials investigating their impact on clinical outcome. The neurocritical care community must work to ensure that AI incorporates standards to ensure fairness and health equity rather than reflect our biases present in our collective conscience.
© 2021. Springer Science+Business Media, LLC, part of Springer Nature and Neurocritical Care Society.

Entities:  

Keywords:  Artificial intelligence; Big data; Deep learning; Machine learning; Precision medicine

Mesh:

Year:  2021        PMID: 34966957     DOI: 10.1007/s12028-021-01422-x

Source DB:  PubMed          Journal:  Neurocrit Care        ISSN: 1541-6933            Impact factor:   3.532


  3 in total

1.  What's next? The future of Medicare physician payment in the post-SGR era.

Authors:  Matthew R Coffron
Journal:  Bull Am Coll Surg       Date:  2015-07

2.  Systematic analysis of challenge-driven improvements in molecular prognostic models for breast cancer.

Authors:  Adam A Margolin; Erhan Bilal; Erich Huang; Thea C Norman; Lars Ottestad; Brigham H Mecham; Ben Sauerwine; Michael R Kellen; Lara M Mangravite; Matthew D Furia; Hans Kristian Moen Vollan; Oscar M Rueda; Justin Guinney; Nicole A Deflaux; Bruce Hoff; Xavier Schildwachter; Hege G Russnes; Daehoon Park; Veronica O Vang; Tyler Pirtle; Lamia Youseff; Craig Citro; Christina Curtis; Vessela N Kristensen; Joseph Hellerstein; Stephen H Friend; Gustavo Stolovitzky; Samuel Aparicio; Carlos Caldas; Anne-Lise Børresen-Dale
Journal:  Sci Transl Med       Date:  2013-04-17       Impact factor: 17.956

3.  Rescue therapy for vasospasm following aneurysmal subarachnoid hemorrhage: a propensity score-matched analysis with machine learning.

Authors:  Michael L Martini; Sean N Neifert; William H Shuman; Emily K Chapman; Alexander J Schüpper; Eric K Oermann; J Mocco; Michael Todd; James C Torner; Andrew Molyneux; Stephan Mayer; Peter Le Roux; Mervyn D I Vergouwen; Gabriel J E Rinkel; George K C Wong; Peter Kirkpatrick; Audrey Quinn; Daniel Hänggi; Nima Etminan; Walter M van den Bergh; Blessing N R Jaja; Michael Cusimano; Tom A Schweizer; Jose I Suarez; Hitoshi Fukuda; Sen Yamagata; Benjamin Lo; Airton Leonardo de Oliveira Manoel; Hieronymus D Boogaarts; R Loch Macdonald
Journal:  J Neurosurg       Date:  2021-07-02       Impact factor: 5.115

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.